Update in Interstitial Lung Disease 2019.

[1]  G. Raghu,et al.  Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. , 2020, The Lancet. Respiratory medicine.

[2]  F. Martinez,et al.  Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[3]  J. Harris,et al.  Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Diseases. , 2019, American journal of respiratory and critical care medicine.

[4]  F. Martinez,et al.  Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE) , 2019, American journal of respiratory and critical care medicine.

[5]  R. Summer,et al.  Lipid Metabolism: A New Player in the Conundrum of Lung Fibrosis , 2019, American journal of respiratory cell and molecular biology.

[6]  K. Tsoyi,et al.  Palmitic Acid-Rich High Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress. , 2019, American journal of respiratory cell and molecular biology.

[7]  L. Wain,et al.  Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[8]  P. Reyfman,et al.  Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences , 2019, American Journal of Respiratory Cell and Molecular Biology.

[9]  G. Han,et al.  Overexpression of TIM-3 in macrophages aggravates pathogenesis of pulmonary fibrosis in mice. , 2019, American journal of respiratory cell and molecular biology.

[10]  A. Günther,et al.  The oncogene ECT2 contributes to a hyperplastic, proliferative lung epithelial cell phenotype in IPF. , 2019, American journal of respiratory cell and molecular biology.

[11]  M. Selman,et al.  The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. , 2019, Cellular signalling.

[12]  Ø. Molberg,et al.  Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort. , 2019, American journal of respiratory and critical care medicine.

[13]  K. Korach,et al.  microRNA let-7 Downregulates Ligand Independent Estrogen Receptor Mediated Male Predominant Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[14]  F. Martinez,et al.  Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[15]  R. Summer,et al.  Activated Fibroblasts: Gluttonous for Glutamine , 2019, American journal of respiratory cell and molecular biology.

[16]  V. Thannickal,et al.  Modeling Fibrosis in Three-Dimensional Organoids Reveals New Epithelial Restraints on Fibroblasts , 2019, American journal of respiratory cell and molecular biology.

[17]  G. Ligresti,et al.  Nascent Lung Organoids Reveal Epithelium- and BMP-Mediated Suppression of Fibroblast Activation. , 2019, American journal of respiratory cell and molecular biology.

[18]  R. Hamanaka,et al.  Glutamine Metabolism is Required for Collagen Protein Synthesis in Lung Fibroblasts. , 2019, American journal of respiratory cell and molecular biology.

[19]  Biao Hu,et al.  Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow. , 2019, American journal of respiratory and critical care medicine.

[20]  M. Glassberg,et al.  Trends in IPF-related Mortality in the United States: 2000-2017. , 2019, American journal of respiratory and critical care medicine.

[21]  Yutong Zhao,et al.  Preventing Glutaminolysis: A Potential Therapy for Pulmonary Fibrosis , 2019, American journal of respiratory cell and molecular biology.

[22]  Gang Liu,et al.  Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis. , 2019, American journal of respiratory cell and molecular biology.

[23]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[24]  J. Chao,et al.  CircRNA-012091/PPP1R13B-Mediated Lung Fibrotic Response in Silicosis via ER Stress and Autophagy. , 2019, American journal of respiratory cell and molecular biology.

[25]  B. Barna,et al.  PPARγ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model. , 2019, American journal of respiratory cell and molecular biology.

[26]  S. Digumarthy,et al.  Type I Collagen-Targeted PET Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies. , 2019, American Journal of Respiratory and Critical Care Medicine.

[27]  Darshak M Sanghavi,et al.  Clinical Effectiveness of the Anti-Fibrotic Medications for Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[28]  T. Maher,et al.  The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[29]  Ivana V. Yang,et al.  Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[30]  E. Mickler,et al.  Familial Pulmonary Fibrosis and Hermansky-Pudlak Syndrome Rare Missense Mutations In Context. , 2019, American journal of respiratory and critical care medicine.

[31]  R. Hubbard,et al.  The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom. , 2019, American journal of respiratory and critical care medicine.

[32]  B. Stripp,et al.  XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in IPF Airway Epithelia. , 2019, American journal of respiratory and critical care medicine.

[33]  A. Günther,et al.  The Long Non-Coding RNA DNM3OS is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[34]  A. Verma,et al.  Attenuation of Allergen, IL-13- and TGF-α-Induced Lung Fibrosis Following the Treatment of IL-15 in Mice. , 2019, American journal of respiratory cell and molecular biology.

[35]  A. Shilatifard,et al.  Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[36]  Jonathan H. Chung,et al.  Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study. , 2019, The Lancet. Respiratory medicine.

[37]  Madeleine K. D. Scott,et al.  Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study , 2019, The Lancet. Respiratory medicine.

[38]  G. Budinger,et al.  Proteostasis Takes Center Stage in Pulmonary Fibrosis , 2019, American journal of respiratory cell and molecular biology.

[39]  G. Raghu,et al.  Idiopathic Pulmonary Fibrosis Guideline Recommendations. Need for Adherence to Institute of Medicine Methodology? , 2019, Annals of the American Thoracic Society.

[40]  K. Veraldi,et al.  Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis. , 2019, American journal of respiratory cell and molecular biology.

[41]  G. Raghu,et al.  Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. , 2019, The New England journal of medicine.

[42]  S. Nava,et al.  Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. , 2019, American journal of respiratory and critical care medicine.

[43]  K. Brown,et al.  Increasing Hypersensitivity Pneumonitis-related Mortality in the United States from 1988 to 2016. , 2019, American journal of respiratory and critical care medicine.

[44]  B. Yaspan,et al.  Rare Protein-altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis. , 2019, American journal of respiratory and critical care medicine.

[45]  Meilan K. Han,et al.  Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[46]  G. Washko,et al.  Imaging Patterns are Associated with Interstitial Lung Abnormality Progression and Mortality. , 2019, American journal of respiratory and critical care medicine.

[47]  Jonathan H. Chung,et al.  Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases , 2019, Annals of the American Thoracic Society.

[48]  C. Ryerson,et al.  YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis , 2019, Annals of the American Thoracic Society.

[49]  Steven K. Huang,et al.  “Yap”-ing about the Antifibrotic Benefits of Prostacyclin , 2019, American journal of respiratory cell and molecular biology.

[50]  O. Nayler,et al.  The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ , 2019, American journal of respiratory cell and molecular biology.

[51]  J. Leipsic,et al.  Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease , 2019, Annals of the American Thoracic Society.

[52]  Raúl San José Estépar,et al.  Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis , 2019, Annals of the American Thoracic Society.

[53]  C. Hung,et al.  Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis? , 2019, American journal of respiratory cell and molecular biology.

[54]  Seidai Sato,et al.  The Tyrosine Kinase Inhibitor TAS‐115 Attenuates Bleomycin‐induced Lung Fibrosis in Mice , 2019, American journal of respiratory cell and molecular biology.

[55]  K. Batra,et al.  Homozygous Rare PARN Missense Mutation in Familial Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[56]  Jonathan H. Chung,et al.  Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation , 2019, American journal of respiratory and critical care medicine.

[57]  S. Orlov,et al.  Sustained Smad2 Phosphorylation Is Required for Myofibroblast Transformation in Response to TGF-β. , 2019, American journal of respiratory cell and molecular biology.

[58]  J. Hagood,et al.  Outsourcing Invasion, a Novel Function for Extracellular Vesicles in the Lung. , 2019, American journal of respiratory cell and molecular biology.

[59]  T. Betsuyaku,et al.  Deficiency of CRTH2, a Prostaglandin D2 Receptor, Aggravates Bleomycin‐induced Pulmonary Inflammation and Fibrosis , 2019, American journal of respiratory cell and molecular biology.

[60]  R. Sanderson,et al.  Fibronectin on the Surface of Extracellular Vesicles Mediates Fibroblast Invasion , 2019, American journal of respiratory cell and molecular biology.

[61]  M. Peters-Golden,et al.  Special Delivery: A New Package for an Old Antifibrotic Mediator. , 2019, American journal of respiratory cell and molecular biology.

[62]  T. Thatcher,et al.  Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Antifibrotic Prostaglandins , 2019, American journal of respiratory cell and molecular biology.

[63]  G. Kayser,et al.  BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[64]  C. Owen,et al.  Dusting Off IL-9 as a New Therapeutic Target for Pulmonary Fibrosis. , 2019, American journal of respiratory cell and molecular biology.

[65]  D. Lagares.  P311 in Scar Wars: Myofibroblasts Lost without Transforming Growth Factor β Translation. , 2019, American journal of respiratory cell and molecular biology.

[66]  K. Ohta,et al.  IL‐9 Blockade Suppresses Silica‐induced Lung Inflammation and Fibrosis in Mice , 2019, American journal of respiratory cell and molecular biology.

[67]  G. Mutlu,et al.  P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor‐&bgr;1, ‐&bgr;2, and ‐&bgr;3 Translation , 2019, American journal of respiratory cell and molecular biology.

[68]  F. Martinez,et al.  Why Does an Aging Smoker's Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease? , 2019, American journal of respiratory and critical care medicine.

[69]  S. Kritchevsky,et al.  Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study , 2019, EBioMedicine.

[70]  P. Caravan,et al.  Molecular imaging of fibrosis: recent advances and future directions , 2019, The Journal of clinical investigation.

[71]  M. Rojas,et al.  Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall. , 2019, American journal of respiratory cell and molecular biology.

[72]  G. Ligresti,et al.  Survivin IPF: Targeting Cellular Metabolism to Promote Apoptosis in IPF Fibroblasts. , 2019, American journal of respiratory cell and molecular biology.

[73]  Y. Geng,et al.  Mitogen‐activated Protein Kinase‐activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis , 2019, American journal of respiratory cell and molecular biology.

[74]  J. Horowitz,et al.  Glutaminolysis Epigenetically Regulates Antiapoptotic Gene Expression in Idiopathic Pulmonary Fibrosis Fibroblasts , 2019, American journal of respiratory cell and molecular biology.

[75]  C. Hogaboam,et al.  Quercetin Enhances Ligand‐induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo , 2019, American journal of respiratory cell and molecular biology.

[76]  F. Martinez,et al.  Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis. , 2019, American journal of respiratory and critical care medicine.

[77]  D. Schwartz.  Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways. , 2018, Annals of the American Thoracic Society.

[78]  G. Raghu,et al.  Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis , 2018, The New England journal of medicine.

[79]  Takeshi Johkoh,et al.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[80]  R. Borie,et al.  Pulmonary phenotypes associated with genetic variation in telomere-related genes , 2018, Current opinion in pulmonary medicine.

[81]  T. Blackwell,et al.  Endoplasmic reticulum stress in pulmonary fibrosis. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[82]  D. Lynch,et al.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective , 2017, American journal of respiratory and critical care medicine.

[83]  M. Selman,et al.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease , 2017, Nature Reviews Drug Discovery.

[84]  F. Martinez,et al.  A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies , 2017, American journal of respiratory and critical care medicine.

[85]  Jin Ock Kim,et al.  Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress , 2017, PloS one.

[86]  Harry J de Koning,et al.  Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis , 2017, Nature Genetics.

[87]  M. Mino‐Kenudson,et al.  Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models , 2017, Science Translational Medicine.

[88]  Athol U. Wells,et al.  Idiopathic pulmonary fibrosis , 2012, Nature Reviews Disease Primers.

[89]  B. Stripp,et al.  Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. , 2016, JCI insight.

[90]  J. Roman,et al.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. , 2016, Annals of the American Thoracic Society.

[91]  K. Batra,et al.  Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive , 2016, European Respiratory Journal.

[92]  R. Homer,et al.  The Airway in Idiopathic Pulmonary Fibrosis: Protecting the Lung or Promoting Disease? , 2016, American journal of respiratory and critical care medicine.

[93]  Dustin J Maly,et al.  Allosteric Inhibition of the IRE1α RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress , 2014, Cell.

[94]  H. Collard,et al.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[95]  M. Selman,et al.  Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. , 2014, American journal of respiratory and critical care medicine.

[96]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[97]  Kevin J Anstrom,et al.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.

[98]  Luis Fernandez-Luque,et al.  HealthTrust: A Social Network Approach for Retrieving Online Health Videos , 2012, Journal of medical Internet research.

[99]  K. Dahlman-Wright,et al.  Estrogen Signaling via Estrogen Receptor β* , 2010, The Journal of Biological Chemistry.

[100]  Oliver Eickelberg,et al.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[101]  Christoph Lange,et al.  Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.

[102]  F. Martinez,et al.  Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. , 2008, American journal of respiratory and critical care medicine.